Cancer cells can employ several strategies to evade the immune system. One common method is the expression of immune checkpoint proteins such as PD-L1, which can inhibit T-cell activity. Additionally, tumors can create an immunosuppressive microenvironment by recruiting regulatory T cells and myeloid-derived suppressor cells that dampen the immune response.
